Heron Therapeutics, Inc.

HRTX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0000818033

SEC filings (opens in a new tab)

No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Heron Therapeutics, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025 All holders in Q1 2025

13F holders of HRTX: Q1 2025 compared with Q2 2025
Measure	Q1 2025	Of which not filed for Q2 2025	Q2 2025	Change
Holders	165	1	171	+7
Shares	124.8M	56.8K	131.5M	+6.74M (+5.4%)
Value	$274.5M	$125.0K	$272.1M	−$2.26M (−0.8%)

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Heron Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to HRTX in Q2 2025
Institution	Shares	Value	% of portfolio
Jacobs Levy Equity Management, Inc	820,504	$1.70M	0.01%
Walleye Capital LLC	299,790	$620.6K	0.01%
Gsa Capital Partners LLP	297,321	$615.0K	0.04%
Cyndeo Wealth Partners, LLC	248,087	$513.5K	0.03%
Qube Research & Technologies Ltd	132,782	$274.9K	0.00%
Glenmede Investment Management, LP	70,250	$145.4K	0.00%
Simplex Trading, LLC	62,460	$129.0K	0.00%
Squarepoint Ops LLC	59,991	$124.2K	0.00%
Prospera Financial Services Inc	49,665	$102.8K	0.00%
Captrust Financial Advisors	47,621	$98.6K	0.00%
Virtu Financial LLC	39,593	$82.0K	0.00%
Russell Investments Group, Ltd.	20,556	$42.5K	0.00%
Zacks Investment Management	14,899	$30.8K	0.00%
Two Sigma Securities, LLC	14,376	$29.8K	0.00%
R Squared Ltd	12,648	$26.2K	0.01%
Xponance, Inc.	11,893	$24.6K	0.00%
Global Retirement Partners, LLC	4,018	$8.32K	0.00%
Jones Financial Companies LLLP	427	$914	0.00%
Skopos Labs, Inc.	364	$754	0.00%
Rothschild Investment LLC	235	$486	0.00%
Allworth Financial LP	35	$73	0.00%
IFP Advisors, Inc	34	$70	0.00%
Mid-American Wealth Advisory Group, Inc.	24	$50	0.00%
Essential Partners LLC	13	$27	0.00%

Sold out (17)

Institutions that held Heron Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of HRTX in Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Point72 Asset Management, L.P.	4,775,877	$10.5M
EAM Investors, LLC	349,000	$767.8K
XTX Topco Ltd	84,405	$185.7K
Franklin Resources Inc	77,552	$170.6K
Corebridge Financial, Inc.	57,515	$126.5K
Carolinas Wealth Consulting LLC	41,356	$91.0K
ExodusPoint Capital Management, LP	38,699	$85.0K
Cutter & CO Brokerage, Inc.	36,465	$80.2K
Synovus Financial Corp	31,847	$70.1K
HRT Financial LP	29,231	$64.0K
CIBC World Markets Inc.	25,900	$57.0K
Lazard Asset Management LLC	13,815	$30.0K
RFP Financial Group LLC	11,776	$25.9K
Balyasny Asset Management LLC	11,492	$25.3K
Quadcap Wealth Management, LLC	7,000	$15.4K
Coldstream Capital Management Inc	1,224	$2.69K
US Bancorp	726	$1.60K

Not filed for Q2 2025 yet (1)

Institutions that held Heron Therapeutics, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HRTX in Q1 2025 that haven't filed for Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Glenmede Trust Co NA	56,796	$125.0K